Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORP 2: Colchicine for Recurrent Pericarditis
NCT00235079Phase 4Completed
- Sponsor
- ASL TO3
- Start
- Nov 2005
- Primary completion
- Dec 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 4 trial of colchicine in recurrent pericarditis, sponsored by ASL TO3. Started Nov 2005; status: completed.
02
Drugs
colchicine
03
Conditions
recurrent pericarditis
Beyond the preview
Go deeper on NCT00235079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235079.